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been demonstrated but that it would explain the fact that breast-fed babies seldom develop symptoms of rickets.
Consequently we have attempted to determine the vitamin D activity of cow's milk and human milk experimentally in order to ascertain whether the so-called water-soluble vitamin D possesses significant activity. As regards both categories of milk the examination comprised milk as received and milk which we subjected to various treatments.
MATERIALS AND METHODS
Whole milk (35 g fat/l) and skim milk (I g fat/l) were bought from retail dealers. The samples in Expts K2, K6 and K7, respectively, were bought in the months November, February and March. The samples of human milk were obtained in the months November and March (Expts HI and H2, respectively) and were reported to have been collected during the period from the Mth to the eighth day after parturition and to derive from normal women with a normal intake of vitamin D. The content of fat was determined by a standard procedure (Association of Official Analytical Chemists, 1975) . The two samples of human milk examined were found to contain 34 g fat/l each.
Determination of the vitamin D content in the samples was made using a biological assay according to Pharmacopoea Nordica (1964) using eight to ten rats/dose. According to this method the response to the treatment is determined by taking X-ray photographs of the proximal ends of the tibia and is designated by the values 1-12 (Bourdillon's scale). The supplements of vitamin D (standard and sample) were fed separately. In Expts K I and K2 the whole-milk sample was fed in the form in which it was purchased, while for the remaining experiments with cow's milk pretreated samples were fed. Pretreatment of the milk was carried out according to the following procedures :
The unsaponifiable residue was prepared by saponification of the sample with ethanolic potassium hydroxide (I 50 g/l) for 30 min and subsequent extraction with peroxide-free diethyl ether. The diethyl ether was evaporated in vacuum.
In Expt K3 the unsaponifiable residue from skim milk was given dissolved in vegetable oil. In Expts K4 and K5 the skim milk was given in the form of powder obtained by freezedrying (I g powder corresponded to 10.4 ml milk and was found, by analysis, to contain (g/kg): 6-9 fat, 10.6 phosphorus). In the Expts K4 and K5 the animals given doses of standard vitamin D received compensatory supplements of phosphate corresponding to the amounts of P contained in the samples administered to the animals that were given doses of the samples.
In Expts K6 and K7 the pretreatment of 7 1 whole milk involved the preparation of a fraction corresponding to that isolated by Le Boulch et al. (1974) : I 1 milk was concentrated to 300ml by evaporation under reduced pressure and 9ooml ethanol was added. The mixture was filtered and the filtrate was evaporated to dryness. I g powder corresponded to 21.4 ml milk and contained (g/kg) 30 fat, 2.3 P. The fat was determined by a standard procedure (Schweizerische Lebensmittelkommission, 1967) . The first sample of human milk (Expt HI) was examined without pretreatment. The second sample (Expt H2) was given untreated as well as after fractionation. The lipid fraction and the unsaponifiable residue from the water-soluble vitamin D sulphate fraction were obtained from the fractionated milk as described by Sahashi et al. (1967) with the exception that the unsaponifiable residue of the vitamin D sulphate fraction was dissolved in vegetable oil.
Because of the low content of P in human milk it was not considered necessary to give compensatory supplements of P with the standard vitamin D doses. t 50 g of the solution in oil corresponded to 460 ml milk.
$ I g powder corresponded to 104 ml milk. 
RESULTS
Cow's milk. In Expt K I the level of whole-milk dose was based on the assumption that the vitamin D content was 100-200 i.u./l, but no curative effect was observed in the experimental animals compared with negative controls, so that a quantitative result was not obtained (Table I) .
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Human milk, whole ( vitamin D/1, slightly more than the amounts of vitamin D normally stated for the lipid fraction of milk. However, the higher vitamin D activity was not, or not exclusively, due to the occurrence of vitamin D in the aqueous phase of milk, because the P content in milk has an antirachitic effect for which no compensation was made. In order to assess vitamin D activity in the water-soluble fraction of cow's milk an experiment using skim milk was carried out (Expt K3).
As it was not possible to administer sufficiently large doses to the animals, the milk was saponified using alcoholic potassium hydroxide to release vitamin D from any vitamin D sulphate present. The vitamin D released was then extracted by diethyl ether which in turn was evaporated in vacuum. The residue was dissolved in vegetable oil. Values for extent of healing were far below the standard range, and antirachitic activity could not be calculated.
In Expts K4 and K5, in which skim milk was administered as a freeze-dried powder, a value of not more than 4 i.u. vitamin D/1 was obtained from two determinations which did not suggest the presence of considerable amounts of water-soluble vitamin D.
Finally, in Expts K6 and K7 an attempt was made to demonstrate vitamin D activity in the whole-milk fraction prepared according to Le Boulch et al. (1974) . From two determinations values obtained for vitamin D activities were approximately I I and 7 i.u./l respectively, i.e. a mean value of g i.u./l or 0.23 pg cholecalciferol/l. It was not possible to demonstrate any activity that corresponded, even approximately, to that of 4-4 pg cholecalciferol sulphatejl found by Le Boulch et al. (1974) .
Human milk. In Expt HI ( Table 2 ) the milk doses were chosen on the assumption that the milk did contain a large vitamin D activity. If, for example, the extent of healing of the animals given 0.4 and 0 2 ml milk were of the same magnitude as that of the animals given
The total content of vitamin D in milk I 1 0.16 and 0.08 i.u., respectively, the calculated content of vitamin D activity would be 400 i.u./l. However, in the actual assay the extent of healing observed corresponded to only about 0.016 i.u. for the highest dose (0.8 ml milk) and consequently only an approximate value of 20 i.u. vitamin D/1 could be estimated. From the same sample a greater dose (3.4 ml/d) was also given, but in this instance the extent of healing was so low that it was impossible to obtain a definite value.
In Expt Hz administration of 5 ml milk gave a vitamin D activity corresponding to 15 i.u./l. The lipid fraction showed a vitamin D activity corresponding to 12 i.u./l, while the sulphate fraction showed very little curative effect even when a large dose was given, thus a value for vitamin D could not be obtained.
The accuracy at our bioassays may be stated to approximately f 25 % in the normal cases where at least two standard doses and two test doses are supplied and the responses for the high doses (standard and test) are of the same magnitude and likewise for the low doses. In Expt I b the fiducial limits (P < 0.05) have been calculated to 82-123 yo of the found value. However, in Expts K4 and K5 the conditions for the usual statistical treatment of the data were not fulfilled and the fiducial limits were not calculated according to the method. In the cases where the response from only one test dose was available the accuracy has not been calculated.
DISCUSSION
The results reported by Sahashi et We have found that, in rats, neither cow's milk nor human milk bas a significantly higher antirachitic activity than the lipid fraction. Cholecalciferol sulphate isolated by chromatography in the previously mentioned studies was found in greater amounts than that corresponding to the antirachitic activity found by us, therefore we must assume that the greater part must have been present in a form biologically inactive to rats, if the substance isolated by Sahashi et al. (1967) 
